Cramer said ARC remains one of the many REITs that are a great investment for those looking for yield.
For "Speculation Friday," Cramer offered up the final installment in his series on speculative biotech stocks, highlighting diagnostics players
(OPK - Get Report) and
(EXAS - Get Report).
Cramer noted Opko has already risen 62% since he last featured the company on Nov. 7, but the stock still has room to run given Opko's pipeline of products. Opko's leading test, one to detect prostate cancer, could result in 60% fewer biopsies. Meanwhile, Opko also has a thriving drug development business with drugs in the works for anti-nausea as well as two others in Phase III testing. Opko also has solid management.
Exact Sciences is the most speculative, admitted Cramer, but the company's new colon cancer test could replace the need for invasive colonoscopies and be worth up to $1 billion in sales if the company gets Food and Drug Administration approval as expected in 2014.
In the Lightning Round, Cramer was bullish on
Bank of America
Am I Diversified?
In the "Am I Diversified?" segment, Cramer spoke with callers and responded to tweets sent via Twitter to
to see if investors' portfolios have what it takes for today's markets.
The first portfolio included:
Cramer said this portfolio was perfectly diversified.
The second portfolio's top holdings included:
Medical Properties Trust
Cramer also blessed this portfolio as diversified.
The third portfolio had:
Main Street Capital
, CSX and
Green Mountain Coffee Roasters
as its top five stocks.
Cramer said "good job" for choosing this portfolio.
No Huddle Offense
In his "No Huddle Offense" segment, Cramer once again praised Ben Bernanke for not listening to the economists and academics and keeping his eye on the prize -- creating jobs and not repeating the mistakes of history.
Cramer reminded viewers that after the Great Depression in 1937, Congress and the president sought to balance the federal budget, a move that sent the economy right back into recession. But Bernanke is committed to not repeating those mistakes and continues to flood the market with money to help spur growth and jobs.
Cramer said the economists and those in Washington should stop worrying about when Bernanke will raise rates and instead focus on how to help him in his efforts.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here:
Follow Scott on Twitter
or get updates on Facebook,